IONIS PHARMACEUT reported $141K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alnylam Pharmaceuticals ALNY:US $ 1.2M 0.01M
Arena Pharmaceuticals ARNA:US $ 0.01M 0M
Astellas Pharma 4503:JP Y 103001M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Bluebird Bio BLUE:US $ 0.7M 0.02M
Dicerna Pharmaceuticals DRNA:US $ 0.01M 0M
Esperion Therapeutics ESPR:US $ 27K 1000
Exelixis EXEL:US $ 0.32M 0M
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Mirati Therapeutics MRTX:US $ 0.05M 0M
Moderna Inc MRNA:US 40.5K 40.5K
Nektar Therapeutics NKTR:US $ 0.02M 0M
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 901M 12M
Omeros OMER:US $ 625K 1000
Ptc Therapeutics PTCT:US $ 0.07M 0M
Regeneron Pharmaceuticals REGN:US $ 0.1M 0M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.56M 0.03M